Biot, France

Gilles Ouvry

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gilles Ouvry

Introduction

Gilles Ouvry is a prominent inventor based in Biot, France, known for his significant contributions to the field of pharmaceutical research. With a total of eight patents to his name, Ouvry has made remarkable strides in developing novel compounds that target critical biological pathways.

Latest Patents

Among his latest patents are the "Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitors." This invention relates to novel mTOR inhibitor compounds characterized by a specific formula, along with their pharmaceutically acceptable salts. The patent also covers compositions that include these mTOR inhibitor compounds, methods for their production, and their potential uses in therapeutic applications. Another notable patent is focused on mTOR inhibitor compounds with a general formula, emphasizing their role in drug compositions and methods of production.

Career Highlights

Gilles Ouvry is currently associated with Galderma Research & Development, where he continues to push the boundaries of innovation in drug development. His work has been instrumental in advancing treatments that target mTOR pathways, which are crucial in various diseases, including cancer.

Collaborations

Ouvry collaborates with talented professionals in his field, including Etienne Thoreau and Branislav Musicki. These partnerships enhance the research and development process, fostering an environment of creativity and innovation.

Conclusion

Gilles Ouvry's contributions to pharmaceutical research and his innovative patents underscore his role as a leading inventor in the industry. His work continues to pave the way for new therapeutic options, demonstrating the impact of dedicated research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…